Paper23225543
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.
Esparza TJ and 6 others. Ann Neurol, 2013. Cited by 248 papers, by iCite.
Cite this record
ConductScience Library. Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls. Papers, record 23225543. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23225543
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Amyloid beta-Peptides | Major topic |
| Cerebral Cortex | Major topic |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Male | |
| Protein Multimerization |
Source PubMed
Grants15
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R-01-NS065667 | NINDS NIH HHS | United States | R01NS065667 | PubMed and NIH | NIH RePORTER |
| R01 AG013956 | NIA NIH HHS | United States | R01AG013956 | PubMed and NIH | NIH RePORTER |
| R01 NS065667 | NINDS NIH HHS | United States | R01NS065667 | PubMed and NIH | NIH RePORTER |
| P50 AG005681 | NIA NIH HHS | United States | P50AG005681 | PubMed and NIH | NIH RePORTER |
| AG13956 | NIA NIH HHS | United States | R01AG013956 | PubMed and NIH | NIH RePORTER |
| K-23-AG030946 | NIA NIH HHS | United States | K23AG030946 | PubMed and NIH | NIH RePORTER |
| R37 AG013956 | NIA NIH HHS | United States | R01AG013956 | PubMed and NIH | NIH RePORTER |
| K08 NS049237 | NINDS NIH HHS | United States | K08NS049237 | PubMed and NIH | NIH RePORTER |
| P50-AG05681 | NIA NIH HHS | United States | P50AG005681 | PubMed and NIH | NIH RePORTER |
| AG029524 | NIA NIH HHS | United States | K01AG029524 | PubMed and NIH | NIH RePORTER |
| R01 NS065069 | NINDS NIH HHS | United States | R01NS065069 | PubMed and NIH | NIH RePORTER |
| P01-AG03991 | NIA NIH HHS | United States | P01AG003991 | PubMed and NIH | NIH RePORTER |
| P30 NS057105 | NINDS NIH HHS | United States | P30NS057105 | PubMed and NIH | NIH RePORTER |
| K01 AG029524 | NIA NIH HHS | United States | K01AG029524 | PubMed and NIH | NIH RePORTER |
| R37AG013956 | NIH | NIH RePORTER |
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9600986 | Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9600986 | PubMed |
| 2 | 9395306 | Hemin and related porphyrins inhibit beta-amyloid aggregation. | FEBS Lett | 1997 | https://conductscience.org/library/papers/9395306 | PubMed |
| 3 | 20682338 | Traumatic brain injury reduces soluble extracellular amyloid-β in mice: a methodologically novel combined microdialysis-controlled cortical impact study. | Neurobiol Dis | 2010 | https://conductscience.org/library/papers/20682338 | PubMed |
| 4 | 9862640 | Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. | J Neuropathol Exp Neurol | 1998 | https://conductscience.org/library/papers/9862640 | PubMed |
| 5 | 7857653 | Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. | Neuron | 1995 | https://conductscience.org/library/papers/7857653 | PubMed |
| 6 | 19523517 | Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. | Neurobiol Dis | 2009 | https://conductscience.org/library/papers/19523517 | PubMed |
| 7 | 12925731 | Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12925731 | PubMed |
| 8 | 18417702 | Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. | J Neurosci | 2008 | https://conductscience.org/library/papers/18417702 | PubMed |
| 9 | 17116235 | Monoclonal antibodies that target pathological assemblies of Abeta. | J Neurochem | 2007 | https://conductscience.org/library/papers/17116235 | PubMed |
| 10 | 10072051 | Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. | Ann Neurol | 1999 | https://conductscience.org/library/papers/10072051 | PubMed |
| 11 | 19001171 | Frequent amyloid deposition without significant cognitive impairment among the elderly. | Arch Neurol | 2008 | https://conductscience.org/library/papers/19001171 | PubMed |
| 12 | 16469784 | Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. | J Physiol | 2006 | https://conductscience.org/library/papers/16469784 | PubMed |
| 13 | 19376612 | Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. | Neurobiol Aging | 2009 | https://conductscience.org/library/papers/19376612 | PubMed |
| 14 | 19228947 | Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19228947 | PubMed |
| 15 | 18824027 | Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates. | J Neurosci Methods | 2009 | https://conductscience.org/library/papers/18824027 | PubMed |
| 16 | 17623042 | Sensitive ELISA detection of amyloid-beta protofibrils in biological samples. | J Neurochem | 2007 | https://conductscience.org/library/papers/17623042 | PubMed |
| 17 | 10950879 | X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. | J Histochem Cytochem | 2000 | https://conductscience.org/library/papers/10950879 | PubMed |
| 18 | 12058030 | Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12058030 | PubMed |
| 19 | 20685980 | Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies. | J Neurosci | 2010 | https://conductscience.org/library/papers/20685980 | PubMed |
| 20 | 14661937 | Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. | Pharm Res | 2003 | https://conductscience.org/library/papers/14661937 | PubMed |
Cited by176
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 248 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42720909 | Amyloid-β PET Radioligands in Alzheimer's Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring. | Mol Diagn Ther | 2026 | https://conductscience.org/library/papers/42720909 | PubMed |
| 42660456 | Apolipoprotein E lipidation, rather than isoform identity, determines amyloid-β binding and astrocyte clearance. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42660456 | PubMed |
| 42377771 | Investigating a relation between amyloid beta plaque burden and accumulated neurotoxicity caused by amyloid beta oligomers. | Med Biol Eng Comput | 2026 | https://conductscience.org/library/papers/42377771 | PubMed |
| 42282610 | Aβ Aggregates Bind the U1 Spliceosomal Ribonucleoprotein in Alzheimer Disease Brain. | bioRxiv | 2026 | https://conductscience.org/library/papers/42282610 | PubMed |
| 42141350 | Amyloid Plaques Ameliorate Memory Deficits and Hippocampal Neuron Loss in an Aβ4-42-Driven Alzheimer's Disease Mouse Model. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42141350 | PubMed |
| 41981185 | Anti-amyloid antibody equilibrium binding to Aβ aggregates from human Alzheimer's disease brain. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/41981185 | PubMed |
| 41820797 | In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances. | Protein Sci | 2026 | https://conductscience.org/library/papers/41820797 | PubMed |
| 40864225 | Donepezil and Memantine Derivatives for Dual-Function and Prodrug Applications in Alzheimer's Disease. | ACS Chem Neurosci | 2025 | https://conductscience.org/library/papers/40864225 | PubMed |
| 40828109 | Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight. | Pharm Pat Anal | 2024 | https://conductscience.org/library/papers/40828109 | PubMed |
| 40646564 | An improved immunoassay detects Aβ oligomers in human biofluids: their CSF levels rise with tau and phosphotau levels. | Alzheimers Res Ther | 2025 | https://conductscience.org/library/papers/40646564 | PubMed |
| 40584900 | The promise of gene therapy in common types of dementia. | Bioimpacts | 2025 | https://conductscience.org/library/papers/40584900 | PubMed |
| 40509358 | N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer's Disease Research. | Molecules | 2025 | https://conductscience.org/library/papers/40509358 | PubMed |
| 40136948 | Recent Advances in Electrochemical Biosensors for Neurodegenerative Disease Biomarkers. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/40136948 | PubMed |
| 40030015 | Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40030015 | PubMed |
| 39939821 | Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer's disease model mice. | Nat Aging | 2025 | https://conductscience.org/library/papers/39939821 | PubMed |
| 39726673 | Monoclonal Antibody Treatments for Alzheimer's Disease: Aducanumab and Lecanemab. | Discoveries (Craiova) | 2023 | https://conductscience.org/library/papers/39726673 | PubMed |
| 39013601 | Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting. | Pharmacol Rev | 2024 | https://conductscience.org/library/papers/39013601 | PubMed |
| 38992064 | Targeting soluble amyloid-beta oligomers with a novel nanobody. | Sci Rep | 2024 | https://conductscience.org/library/papers/38992064 | PubMed |
| 38916729 | Tryptophan Metabolism in Alzheimer's Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis. | Aging Dis | 2024 | https://conductscience.org/library/papers/38916729 | PubMed |
| 38902572 | Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model. | Drugs | 2024 | https://conductscience.org/library/papers/38902572 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| MB | 4151 | PubTator's text mining | https://conductscience.org/library/genes/4151 | NCBI Gene |
| TG | 7038 | PubTator's text mining | https://conductscience.org/library/genes/7038 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23225543
GET https://conductscience.org/api/papers/v1/23225543/references?page=2